Abstract: Intrahepatic cholangiocarcinomas are histologically heterogenous. Using a cohort of 184 clinically defined, resected intrahepatic cholangiocarcinomas, we retrospectively classified the histology into 4 subtypes: large duct (LD), small duct (SD) (predominantly tubular [SD1] or predominantly anastomosing/ cholangiolar, [SD2]), or indeterminate. Then, we tested the 4 subtypes for associations with risk factors, patient outcomes, histology, and immunophenotypic characteristics. SD was the most common (84%; 24% SD1 and 60% SD2) with lower proportions of LD (8%), and indeterminate (8%). Primary sclerosing cholangitis was rare (2%), but correlated with LD (P = 0.005). Chronic hepatitis, frequent alcohol use, smoking, and steatosis had no histologic association. LD was associated with mucin production (P < 0.001), perineural invasion (P = 0.002), CA19-9 staining (P < 0.001), CK7 + , CK19 + , CD56
C
arcinomas arising from the bile ducts are divided into intrahepatic, perihilar, and extrahepatic types based on site of anatomic origin. Intrahepatic cholangiocarcinomas (ICCs) have an incidence of 1 per 100,000 in the United States. 1 ICCs putatively arise from cholangiocytes beyond the second order of branching ducts of the intrahepatic biliary tree, and variations in cell function and morphology along this bile conduit may account for the well known heterogeneity of architectural patterns seen in these neoplasms.
Macroscopic classification of ICC as mass forming, periductal infiltrating, and intraductal types has significance for resectability. 2 Histologically, it is clear that the anatomic distribution of the tumor does not rigidly equate with the microscopic morphology, with some ICCs resembling the carcinomas of the hilar and extrahepatic bile ducts. The relevance of classifying ICC into histologic subtypes is less certain, particularly given the inconsistent and imprecise use of terminology. [3] [4] [5] [6] One proposed binary histologic classification divides ICC into large duct (LD) ICC (aka perihilar, hilar, bile duct) and small duct (SD) subtypes (aka peripheral, cholangiolar, bile ductular), based on resemblance of the more well differentiated areas to benign bile ducts of similar size and cholangiocyte morphology. 7 The neoplastic cells of the SD subtype are cuboidal to polygonal and line either small welldefined tubules resembling interlobular bile ducts or small anastomosing glands resembling bile ductular reaction or canals of hering (so-called cholangiolocellular carcinoma). 8, 9 The LD subtype is composed of columnar cells lining irregularly infiltrating large glands, more commonly producing mucin and associated with a desmoplastic stromal response, and the neoplasms tend to be located closer to the large bile ducts in the perihilar portions of the liver. 10 Immunohistochemistry has been used to investigate theories of ICC carcinogenesis and the results could inform subtyping. For example, the similarity between SD ICC and the bile ductular/cholangiolocellular components of so-called mixed hepatocellular-cholangiocarcinomas with stem cell features has led to the theory that both tumors arise from hepatocellular progenitor cells in the bile ductules that possess the potential for either hepatocytic or cholangiocytic differentiation. Hepatocellular progenitor cells label with CD56 (NCAM), CK7, SALL4, Okt4, CRP, and CK19 and neoplasms with bile ductular-like growth patterns stain similarly. 7, [11] [12] [13] In contrast, the LD subtype is negative for CD56 and has S100P expression. 5, 7, 10 Albumin RNA in situ hybridization is a sensitive and highly specific method for diagnosing carcinomas of intrahepatic origin but this marker has not been explored in ICC subtypes. 14 Most affected patients have no known risk factors for ICC. However, disease associations, including chronic hepatitis, parasitic infections, and autoimmune disease, have an effect on the incidence of disease worldwide. If specific risk factors are associated with histologic subtypes it could influence the prevalence of subtypes in different populations.
The purpose of this study was to undertake histologic subclassification of ICCs and assess their correlations with immunophenotype, clinical features, and outcome, using one of the largest North American cohorts of resected neoplasms.
MATERIALS AND METHODS

Case Selection
We selected ICCs resected at Memorial Sloan Kettering Cancer Center from a prospectively maintained institutional database (January 1993-2014) with institutional review board approval. All patients were determined on a clinical basis to have a primary liver cancer by routine investigations including clinical characteristics, imaging studies, and upper and lower gastrointestinal endoscopy when indicated, and surgical findings. The study population included a subset of patients reported in an analysis of recurrence patterns reported previously by our institution. 15 Patients with hilar, extrahepatic cholangiocarcinoma, purely intraductal neoplasms, invasive carcinomas arising in association with mucinous cystic neoplasms, and combined hepatocellular-cholangiocarcinoma were excluded. Patients with embolization therapy or neoadjuvant therapy were included as long as the majority of tumor was viable. All available tumor slides (total of 1 to 19 slides per patient, median = 6 slides) were reviewed. Clinical data including history of cirrhosis, autoimmune disease, primary sclerosing cholangitis, smoking, and alcohol use were obtained retrospectively from the electronic medical record. The presence or absence of viral hepatitis was recorded only for patients with a clinical history or laboratory record of prior serologic testing for chronic hepatitis B (HBsAg + ) or C (HCV-Ab). Frequent alcohol use history was defined as > 15 drinks/week for men and > 8 drinks/week for women.
Gross and Histologic Variables
The following histologic parameters were assessed on all available tumor slides (whole tissue section) with consensus among 3 pathologists (C.S.S., O.B, Y.Z.): nodular growth (Figs. 1A, B) , zones of histologic patterns (Fig. 1C) , intracellular and extracellular mucin, an infiltrative interface (Fig. 1D ), hepatoid cytology (Fig. 1E) , and the character of intratumoral stroma. "Zones of histologic patterns" was defined as the presence of abrupt transitions between areas of distinct architectural patterns (Figs. 1C, 2A, F) . "Nodularity" was defined at low power when aggregates of proliferating glands had a rounded contour (Figs. 1A, B ). An infiltrative interface by tumor was defined as tumor cells infiltrating the liver plates at the junction between liver and tumor (Fig. 1D) . Hepatoid cytology was defined as polygonal cells with eosinophilic cytoplasm in the absence of immunohistochemical evidence of actual hepatocellular differentiation (Fig. 1E) . Intratumoral stroma was categorized as scar (broad area of stroma with no viable tumor), desmoplastic stroma (prominent interglandular pale stroma rich in myofibroblast-like cells (Fig. 3A) , sclerotic (prominent dense, sclerotic eosinophilic hypocellular interglandular stroma) (Figs. 1C, F), or stroma poor (minimal interglandular stroma/ back to back glands) (Figs. 1E, 2D, H) .
American Joint Committee on Cancer (AJCC) eighth edition pT stage was assigned to each case using histopathologic parameters. 16 Gross configuration (periductal infiltrating versus mass forming) was determined using the American Joint Committee on Cancer TNM classification, seventh edition (Figs. 2I, 3D) . 16, 17 "Mixed" mass forming and periductal infiltrating tumors were classified as periductal infiltrating. Lymphovascular invasion included small and large vessel invasion. Background steatosis was defined as > 50% steatosis.
Criteria for Classification into LD, SD, and Indeterminate Subtypes
Two pathologists (C.S.S., T.W.) assigned histologic grade and subtype by reviewing all available tumor slides (whole tissue sections) and estimating the percentage of solid, large tubular, small tubular, and anastomosing glands. From this raw data (not shown), histologic grade was assigned using this definition: well differentiated had <75% solid growth pattern; poorly differentiated had ≥ 25% solid growth pattern. LD was assigned to tumors with a predominant component of large irregularly infiltrating glands lined by columnar cells (Figs. 3A-F) . Tumors with limited areas of micropapillary growth and/or focal small tubular patterns were allowed in this category. SD was assigned to tumors with a predominant component of cuboidal to polygonal cells lining predominantly small to intermediate sized tubules and/ or anastomosing glands (Fig. 2) . Tumors with foci of dilated tubular ducts were included if the cells lining the tubules were cuboidal ( Fig. 2A) . Given that a spectrum of morphology was anticipated, areas of solid, confluent, or cribriform growth of glands were acceptable in SD and LD subtypes and quantified for the purposes of grading as described previously; the subtype was thus defined based on the better differentiated regions of the neoplasms. SDs were subclassified as SD1 (a.k.a. bile duct type) if the well differentiated component contained predominantly nonanastomosing tubules resembling interlobular bile ducts (Fig. 2B) ; and SD2 (a.k.a. bile ductular type, cholangiolar) if the well differentiated component contained predominantly anastomosing tubules focally resembling a bile ductular reaction (Fig. 2E) . Neoplasms with areas resembling a ductal plate malformation (Fig. 2F) or cholangiocellular carcinoma pattern (Figs. 1F, 2E) were included in SD2 because the glands in that pattern are anastomosing. 18 An estimated percentage of the cholangiocellular carcinoma pattern component was recorded, defined as a proliferation resembling the canals of Hering (Figs. 1F, 2E ). Cases with features that did not 
Ancillary Studies
Paraffin embedded tissue microarrays (TMA) were constructed using 2 to 4 1.0 mm diameter punches from each neoplasm, targeted to represent the various morphologic patterns that were present. Immunohistochemistry for antibody (dilution, clone, manufacturer) were as follows: HepPar1 (1:2000, OCH1E5, Dako), Arginase-1 (1:1000, Cell Marque), Glypican-3 (1:100, Santa Cruz); S100P (1:5000, Dako); CD56 (1:50, MRQ42, Cell Marque); CK19 (1:400, RCK108, Dako); CA19.9 (Ventana); and CK7 (1:1000, OV-TL12130, Dako) were performed using standard immunoperoxidase methods and the manufacturer's instructions. Immunohistochemical stains with > 20% strong tumor cell labeling were scored as positive. Extracellular and intracellular mucin production was assessed by 2 different methods: by Hematoxylin and eosin (H&E) stain whole tissue section or mucicarmine stains (TMA). Mucin was scored as extracellular if any mucin was identified in the luminal spaces or intracellular if within the confines of the cytoplasm.
Albumin RNA in situ hybridization was performed using 2 automated platforms: albumin RNA ISH by ViewRNA ISH cell assay kit (ThermoFisher Scientific, Waltham, MA) and Advanced cell diagnostics system by Leica Biosystems (Buffalo Grove, IL), performed on the Leica BOND III autostainer. Both methods were performed according to the manufacturers' instructions for the assay kits. All cases stained with ViewRNA ISH had verification of positive housekeeping mRNA-targeting Probe set, Pan HKG (ThermoFisher Scientific) and negative DAP B controls (ThermoFisher Scientific). Staining in each case was evaluated on 2 to 4 1.0 mm diameter punches prepared in a formalin-fixed paraffin-embedded TMA. Positive staining by either method was scored as positive, using a threshold of granular staining in the cytoplasm of at least 5% of tumor cells. Negatively staining tumors on TMA had repeat staining performed on whole tissue sections as feasible.
Clinical Outcome Data Collection
Recurrence-free survival (RFS) was defined as the interval between resection and the date of disease recurrence which was defined as radiographic appearance of a new lesion (intrahepatic recurrence or metastasis) compatible with ICC or date of disease-specific death for patients with no clinical date of recurrence. Patients without recurrence were censored at the date of last clinical encounter. Diseasespecific survival (DSS) was defined as the interval between resection and death from ICC. Patients without ICC-related death were censored at the date of the last follow up or noncholangiocarcinoma-related death. Thirteen patients with a history of neoadjuvant therapy and 4 patients resected for recurrent liver disease were excluded from survival analysis.
Statistical Analysis
To ascertain differences in the rates of clinical characteristics and histologic features among the 4 histologic subtypes we performed 3 analyses: comparison SD1 versus SD2, SD versus LD, and all types (SD1 vs. SD2 vs. LD vs. IND). Categorical variables were compared using the Fischer exact test and χ 2 test. All P-values were based on 2-tailed statistical analysis with a threshold of <0.05 for statistical significance. Cox regression for survival analysis was performed to compare hazard rates of histologic types and other characteristics. Analysis was performed using R statistical software version 3.4.1.
RESULTS
Clinical Characteristics of ICC
A total of 184 ICC patients were included with a median age of 66 years. Demographics and clinical characteristics are summarized in Table 1 . Women outnumbered men (103 women: 81 men) and there was an ethnic predominance of white patients (89%). Hepatitis serology was available for 110 patients, with a 17% prevalence of chronic viral hepatitis. The cohort had a high prevalence of smoking (46%) and low prevalence of frequent alcohol use (9%), cirrhosis (8%), autoimmune disease (8%), steatosis (3%), and primary sclerosing cholangitis (2%). There were no instances of major risk factors for cholangiocarcinoma in other geographic settings such as hepatic lithiasis, parasitic infection, and anatomic malformations.
Correlation Between Histologic Type and Clinical Risk Factors
The only risk factor for cholangiocarcinoma that showed an association with a histologic subtype was primary sclerosing cholangitis, which was rare, but had a significantly increased association comparing LD versus SD types (P = 0.018) ( Table  S1 , Supplemental Digital Content 1, http://links.lww.com/PAS/ A664). Comparison of SD1 vs SD2 showed no statistically significant association (P > 0.05) with clinical risk factors (chronic hepatitis, steatosis, cirrhosis, autoimmune disease, primary sclerosing cholangitis, alcohol, and smoking).
Distribution of Histopathologic Features and Gross Configuration by Histologic Subtype
The distribution of histologic subtypes in this cohort was 24% SD1, 60% SD2, 8% LD, and 8% IND. Table 2 summarizes the results of analyses performed to identify whether certain histopathologic features were seen at higher rates among the histologic subtypes. The vast majority, 155 (84%) of the cases, were SD and only one histologic feature distinguished SD1 from SD2 when these 2 subtypes were compared: fewer cases of SD1 had zones of histologic patterns (20% vs. 46%; P = 0.003).
In contrast, several histologic features occurred in LD at rates distinctly different from the other types and although there were a few exceptions, the differences were significant when analysis included all types and when restricted to LD versus SD (Table 2 and Table S2 , Supplemental Digital Content 1, http://links.lww.com/PAS/A664). This finding supports the greater similarities between SD1 and SD2 compared with LD. Comparing LD versus SD, LD had significantly higher rates of perineural invasion (71%), extracellular mucin (79%), intracellular mucin by H&E (79%), and lower rates of hepatoid cytology (none), infiltrative interface (29%), and sclerotic stroma (29%). The rate of desmoplastic stroma was similar between LD (57%) and IND (53%), but significantly different from SD1 (18%) and SD2 (13%) in analysis of all types (Table S2 , Supplemental Digital Content 1, http://links. lww.com/PAS/A664). Nodularity was present in fewer cases of LD compared with SD (7% vs. 39% P = 0.019). No difference in AJCC eighth edition pT stage was detected among subtypes.
The IND type had few distinguishing features in the analysis of all types (Supplemental Table 2 , Supplemental Digital Content 1, http://links.lww.com/PAS/A664). IND had a higher rate of high grade tumors (73%) compared with the other types (14% to 33%) and a low rate of zones of histologic patterns (20%). These findings are not surprising because this category contained carcinomas with mostly solid architecture with gland formations too limited to categorize as LD or SD, and it also included adenosquamous carcinomas.
Histologic features that showed no significant associations (P > 0.05) with the subtypes included lymphovascular invasion, lymph node metastasis, satellite nodules, stroma poor, and scar.
Most tumors (90%) were mass forming. Histologic subtypes did not show an association with mass forming or periductal infiltrating type (P > 0.05); however, this configuration was present in a minority of cases overall (9%). There were too few tumors associated with an intraductal neoplasm to evaluate for associations.
Mucin Stain and Albumin Expression
Mucicarmine staining (on TMA) detected extracellular mucin in 28% of SD1, 18% of SD2, 82% of LD, and 25% of IND subtypes (P < 0.001, Table 3 ) which is consistent with the significant association between LD and extracellular mucin detected on H&E whole tissue section. Unexpectedly, intracellular mucin was identified in fewer LD type on the mucin stained TMA compared with the whole tissue section H&E evaluation (27% vs. 79% positive staining) and consequently we saw no significant association between intracellular mucin stain positive cases and subtype in all analyses. This discrepancy could be attributed to sampling as the glandular density in LD is greatly reduced compared with SD, with few glands represented on some samples in the TMA.
By mucin stain there was no significant difference in intracellular or extracellular mucin comparing SD1 versus SD2 (P > 0.05). Select histologic features were tested for associations with mucin staining (Table 4) . Neoplasms negative for extracellular mucin correlated with a lack of periductal infiltration (P = 0.038). No correlation was seen between mucin (intracellular or extracellular) staining, grade, and > 10% cholangiocellular carcinoma pattern (P > 0.05). Albumin expression was positive in 18% of LD, which was significantly lower compared with albumin expression by the other types (53% to 78% positive) (P = 0.001). The higher rate of albumin expression in SD2 (78% positive) compared with SD1 (53% positive) was statistically significant (P = 0.018). Albumin expression was also associated with a > 10% cholangiocellular carcinoma pattern (P = 0.004) ( Table 4) . Of the 44 cases testing negative for albumin on TMA, 30 (68%) were repeated on whole tissue section. Ten cases that were negative on TMA were positive on whole tissue section.
We identified a significant correlation between albumin expression and extracellular mucin production; of the 84 albumin positive tumors, only 13 (15%) were positive for extracellular mucin by mucin stain (P < 0.001) (Table 4) . However, there was no correlation between albumin expression and intracellular mucin by mucin stain (P > 0.05).
Immunophenotype of the Morphologic Subtypes
Significant immunophenotypic differences were detected between LD and SD (Table 3) . Compared with SD, LD showed higher rates of CA19-9 expression (73%) and the CK7 + , CK19
− phenotype (91% of LD positive).
Comparing SD1 and SD2, there was no difference in expression of CA19-9, the CK7 + , CK19 + , CD56
− phenotype, CD56, and S100P (P > 0.05). S100P was rarely positive in SD (SD1 4% and SD2 8%).
Select histologic features were tested for associations with immunophenotype (Table 4) . CA19-9 expression correlated with periductal infiltration (P = 0.007). The CK7 + /CK19 + /CD56 − phenotype, CD56, and S100P expression did not show an association with periductal infiltration, > 10% cholangiocellular carcinoma pattern, or grade. CA19-9 expression correlated with a lack of albumin staining (P < 0.001).
We tested markers that are associated with hepatocellular differentiation: HepPar1 was focally positive in 1 of 128 tested cases; Arginase was negative in all 127 tested cases. Glypican-3 was negative in 127 tested cases.
Outcome After Resection
The median follow up for this cohort was 37 months (interquartile range, 19 to 73 mo). AJCC eighth edition pT stage and periductal infiltration were significant predictors of reduced RFS and DSS by univariate and multiple variable analysis accounting for pT stage, gross configuration, and histologic subtype (combined LD/IND) ( Tables 5, 6 ). Periductal infiltration was seen in 17 cases and all would have been pT4 in the AJCC seventh edition, but in the eighth edition were distributed as follows: pT1 (2 cases), 8 pT2 (8 cases), 7 pT3 (7 cases). As a likely consequence, there were only 3 pT4 cases (this cohort was limited to resectable disease) and pT2 had the highest hazard ratio in time-to-event analysis. Time-to-event analysis for RFS and DSS across the histologic subtypes, using SD2 as a reference, only reached significance in univariate analysis if LD and IND were combined; however, after accounting for multiple variables, the differences in time-to-event for LD/IND was not significant.
DISCUSSION
ICC has a higher prevalence in Asia over North America, but its incidence is rising in the western hemisphere. 19 In the 2010 WHO classification of tumors of the digestive system, there is no subtyping of ICC (excluding rare variants). 20 However, several investigators have proposed dividing ICC into 2 or more histologic types. 4, 5, 7, 10, 21, 22 Our primary aim was to assess if architectural patterns in a large North American cohort of resected ICC would show clinical and pathologic associations that have been previously observed in other (primarily Asian) populations.
The only clinical risk factor that showed an association with histologic subtype was primary sclerosing cholangitis which was rare (2%) but correlated with the LD subtype. SD has been reported to associate with chronic hepatitis but we did not detect this. 8 Prevalence of chronic hepatitis B and C in this study group (17%) is higher than the US population (< 2% hepatitis B and 1.3% hepatitis C, respectively) but lower than the prevalence in other studies of ICC histology (range: 29% to 57%). 5, 7, 8, 11, 21, 23, 24 In this study, where subtyping was performed purely based on histologic parameters, we provide additional support for histopathologic and immunophenotypic differences distinguishing LD from SD. Compared with SD, LD has higher rates of intracellular and extracellular mucin, desmoplastic stroma, and perineural invasion, while SD has higher rates of an infiltrative tumor/liver interface, nodularity, sclerotic stroma, and hepatoid cytology. The 2 subtypes also show distinct staining patterns: in LD, albumin is less likely detected by ISH and CA19-9 is more often positive than in SD. Other authors have shown differences between LD and SD including a unique LD immunophenotype (S100P, TFF1, galectin-3, and AGR2 expression, absent N-cadherin) and a higher prevalence of KRAS mutation. 8, 21, 22, 25, 26 Many features of LD are also seen in extrahepatic and hilar cholangiocarcinoma. We did not reproduce a previously reported association between S100P expression and LD type but showed a high proportion of the "mature cholangiocyte" CK7 + , CK19 + , CD56 − phenotype. 11 The majority (84%) of ICC in this cohort was SD and this finding is divergent from generalized descriptions that most ICC resemble adenocarcinomas of the hilar, extrahepatic, or pancreatobiliary type. 20 In fact, LD type (9%) in this study was vastly underrepresented compared with other studies of ICCs that report ranges from 41% to 59%. 5, 7, 10, 21, 22 The proportion of periductal infiltrating type (10%) in our study was also low in comparison to others (range: 12% to 28%). 7, 21, 27 Reasons for these differences include case selection, epidemiology, variation in histologic criteria between studies, and use of immunohistochemistry for diagnosis. 7, 10 In the present study, case selection was not entirely consecutive and excluded tumors determined to be of hilar origin on a clinical basis. Clinical distinction between intrahepatic versus extrahepatic perihilar origin is known to be challenging, particularly in large tumors involving the hilum. 28 Epidemiologic factors also contributed to this difference. For example, a Taiwanese cohort had 59% LD ("bile duct" type in their study) and a 13% rate of hepatic lithiasis which is a risk factor associated with LD type that was absent in our population. 21 Another factor is the lack of consensus among pathologists for large and small duct classification. Unlike some studies, we did not include mucin production as a criterion for categorization because it can be present in both types, although in different proportions. 7, 10 Other authors have used S100P to increase recognition of LD. 7, 27 We did not apply S100P results to classification but it would be unlikely to have reclassified many SD cases because only 8 (7%) non-LD cases (1 SD1 cases, 6 SD2 cases) expressed S100P. We tested for S100P on a TMA but that is not a major limitation because S100P positive cholangiocarcinomas tend to have diffuse reactivity. 29 We did not detect a significant difference in survival for LD versus SD, but the analysis was likely limited by the low proportion of LD.
AJCC eighth edition pT stage is a predictor of survival, but pT2 had the highest hazard ratio among T stage categories in our time-to-event analysis. Our finding that periductal infiltration was also an independent predictor of survival would argue against the recent removal of this criterion from the pT4 category in the eighth edition of the AJCC cancer staging manual.
Recent improvements in automated technology for detecting albumin mRNA have increased the clinical applicability of this marker for the diagnosis of ICC but it is still not widely used in practice. Prior studies on albumin detection in ICC have reported variable results, which is likely due to differences in methodologies and case selection. [30] [31] [32] [33] Ferrone and colleagues reported on the same ICC cohort, suggesting albumin RNA ISH may help in distinguishing ICC perihilar (extrahepatic) cholangiocarcinoma from intrahepatic carcinomas because 99% of ICC had 5% to 100% albumin staining on TMA. 14, 32 In contrast, Coulouarn et al 33 detected albumin in a much smaller proportion (33%) of ICC. Neither study described histomorphology of the ICC tested. Our study provides some insight into potential limitations of the albumin stain as a marker for working up a liver biopsy containing an unknown primary neoplasm. Although we found albumin expression in 66% of ICCs overall, we conclude that albumin staining is unlikely to be useful to support intrahepatic origin for neoplasms with a LD morphology, as 82% are negative. Negative albumin staining on small biopsies of tumors with a SD pattern should not exclude intrahepatic origin. As the IND subtype stained with albumin in 64% of cases, it may still be useful to rule in intrahepatic origin in the context of neoplasms lacking a well differentiated SD pattern suggesting cholangiocarcinoma. The significant correlation between > 10% cholangiocellular carcinoma pattern and positive albumin expression suggests that this histologic pattern, when present, may be helpful in suggesting intrahepatic origin when albumin staining is not available.
Like Hayashi et al, 7 our comparison of SD1 and SD2 ICC does not support subdividing the SD category because there are very limited clinical, histological, or immunophenotypic differences distinguishing them. Distinction of SD1 from SD2 can be difficult when there are only small amounts of well differentiated glands. Compact, angulated, and dilated glands can also be difficult to consistently classify as anastomosing versus tubular.
Nomenclature for subtypes of ICC is confusing because terms used to describe the anatomy of the liver and bile ducts overlap with terms used to describe histologic subtypes. For example, ICC is often termed, "peripheral" cholangiocarcinoma because it arises peripheral to the second order bile ducts at the hilar biliary confluence, but this terminology should be discouraged because these tumors occur throughout the liver parenchyma including central or adjacent to the liver hilum. 34 Conversely, some clinically intrahepatic carcinomas resemble the carcinomas of the larger bile ducts of the hepatic hilum or extrahepatic bile ducts. Using the terms "hilar" or "perihilar" for these histologic patterns is also problematic because these terms are very specific to the anatomic sites of extrahepatic cholangiocarcinoma and these neoplasms have different staging parameters. As it is accepted that tumors with an LD pattern can arise peripheral to the second order bile ducts, we advocate for the use of SDand LD types in describing the histology of ICC to avoid confusion between histologic pattern and site of tumor origin.
In conclusion, 2 distinct patterns of ICC arise within the liver: LD, which more commonly produces mucin, resembles extrahepatic biliary neoplasms, has a low prevalence in this North American population, has an association with primary sclerosing cholangitis, and tends to lack albumin expression; and SD, the more common pattern in this cohort, is composed of predominantly tubular or anastomosing small ducts and can also produce mucin. At this time we find no compelling argument such as a significant clinical association or known biological significance to justify further subtyping of SD. As we were unable to demonstrate a difference in survival between SD and LD treated primarily by resection, it may not be clinically relevant at this time to report SD versus LD routinely; however, recognition of these 2 morphologic patterns can aid in the interpretation of the albumin stain. Also, the marked difference in the histologic presentation of these 2 types prompts us to advocate that future investigations of the biologic and genetic characteristics of ICC include correlation with these 2 distinct histologic phenotypes so that the biological significance can be better understood.
